AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24131826 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 94
Study 22407240 — intervention group
Group type: EXPERIMENTAL
Intervention: OG tube-guided technique
Number of subjects: 60
Study 22407240 — intervention group
Group type: COMPARATOR
Intervention: Standard digital technique
Number of subjects: 60
Study 20597833 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile telemonitoring
Number of subjects: 137
Study 20597833 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 137
Study 20597833 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile telemonitoring (specifically for patients of African origin)
Number of subjects: 137
Study 20597833 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile telemonitoring (for patients achieving systolic blood pressure <120 mm Hg)
Number of subjects: 137
Study 18703604 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced (18)F-FDG PET/CT
Number of subjects: 50
Study 18703604 — intervention group
Group type: COMPARATOR
Intervention: PET alone
Number of subjects: 50
Study 18703604 — intervention group
Group type: COMPARATOR
Intervention: Unenhanced PET/CT
Number of subjects: 50
Study 15781815 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta-1b
Number of subjects: 708
Study 15781815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 708
Study 12492903 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0625% P‐113 gel
Number of subjects: 106
Study 12492903 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% P‐113 gel
Number of subjects: 106
Study 12492903 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.375% P‐113 gel
Number of subjects: 106
Study 12492903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 12492903 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐113 treatment groups
Number of subjects: 106
Study 10357420 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystectomy performed within 3 months after initial diagnosis
Number of subjects: 138
Study 10357420 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate cystectomy
Number of subjects: 138
Study 10357420 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 138
Study 7860449 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Behavior Problem Questionnaire (CBPQ)
Number of subjects: 611
Study 7860449 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal psychiatric symptoms
Number of subjects: 611
Study 1632542 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine with epinephrine (5 micrograms/mL)
Number of subjects: 20
Study 1632542 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with epinephrine (5 micrograms/mL)
Number of subjects: 20
Study 6092287 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal, 50 g given within 5 min of sotalol hydrochloride (160 mg)
Number of subjects: 7
Study 6092287 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal, repeated doses of 50 g followed by 12.5 g at 6 h intervals
Number of subjects: 7
Study 6092287 — intervention group
Group type: COMPARATOR
Intervention: Control phase (no intervention)
Number of subjects: 7
Study 6092287 — intervention group
Group type: COMPARATOR
Intervention: Acidification or alkalinization of urine for 3 days
Number of subjects: 7
Study 31631796 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography
Number of subjects: 6985
Study 31631796 — intervention group
Group type: EXPERIMENTAL
Intervention: CT or MR angiogram
Number of subjects: 6985
Study 31631796 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic testing
Number of subjects: 6985
Study 30882914 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 or 800 mg UDCA on day 1, followed by 200 mg UDCA twice daily for 2 weeks
Number of subjects: 32
Study 30121146 — intervention group
Group type: EXPERIMENTAL
Intervention: HIVIS-DNA and MVA-CMDR-HIV alone (n=12)
Number of subjects: 25
Study 30121146 — intervention group
Group type: EXPERIMENTAL
Intervention: HIVIS-DNA and MVA-CMDR combined with protein CN54rgp140 (n=13)
Number of subjects: 25
Study 26875065 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection (IA group)
Number of subjects: 126
Study 26875065 — intervention group
Group type: COMPARATOR
Intervention: Subacromial injection (SA group)
Number of subjects: 126
Study 26875065 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined IA and subacromial injections (IA+SA group)
Number of subjects: 126
Study 24390400 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral preservative-free lidocaine 1%
Number of subjects: 100
Study 24390400 — intervention group
Group type: COMPARATOR
Intervention: Intracameral injection of balanced salt solution (sham injection)
Number of subjects: 100
Study 22112807 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily (OD) hydrocortisone dual-release tablet
Number of subjects: 64
Study 20715787 — intervention group
Group type: EXPERIMENTAL
Intervention: Three novel nonsteroidal glucocorticoid receptor agonists applied at low dose in ethanol solution.
Number of subjects: 0
Study 20715787 — intervention group
Group type: EXPERIMENTAL
Intervention: MALDI MSI and LESA with nESI‐MS techniques used for analysis.
Number of subjects: 0
Study 17697555 — intervention group
Group type: EXPERIMENTAL
Intervention: GEMOX regimen (gemcitabine of fixed-dose rate infusion plus oxaliplatin)
Number of subjects: 869
Study 17697555 — intervention group
Group type: COMPARATOR
Intervention: GEM alone (control)
Number of subjects: 869
Study 16270720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine, 10 mg
Number of subjects: 599
Study 16270720 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine, 180 mg
Number of subjects: 599
Study 16270720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 599
Study 16270720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine vs Fexofenadine
Number of subjects: 599
Study 16270720 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 599
Study 12147372 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (30 mg daily)
Number of subjects: 168
Study 12147372 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 168
Study 9914569 — intervention group
Group type: EXPERIMENTAL
Intervention: leuprolide acetate depot
Number of subjects: 51
Study 9914569 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 51
Study 7752652 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-propranolol (2, 10, and 50 micrograms/min)
Number of subjects: 12
Study 7752652 — intervention group
Group type: EXPERIMENTAL
Intervention: (S)-propranolol
Number of subjects: 12
Study 7752652 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-atenolol
Number of subjects: 12
Study 7752652 — intervention group
Group type: EXPERIMENTAL
Intervention: (S)-atenolol
Number of subjects: 12
Study 7752652 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-propranolol
Number of subjects: 12
Study 2270767 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg fluconazole (oral)
Number of subjects: 99
Study 2270767 — intervention group
Group type: COMPARATOR
Intervention: 1200 mg miconazole (intravaginal)
Number of subjects: 99
Study 7230336 — intervention group
Group type: EXPERIMENTAL
Intervention: estramustine phosphate
Number of subjects: 121
Study 7230336 — intervention group
Group type: EXPERIMENTAL
Intervention: estramustine phosphate plus vincristine
Number of subjects: 121
Study 7230336 — intervention group
Group type: EXPERIMENTAL
Intervention: vincristine
Number of subjects: 121
Study 7230336 — intervention group
Group type: COMPARATOR
Intervention: estramustine phosphate, vincristine, estramustine phosphate plus vincristine
Number of subjects: 121
Study 30149982 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based learning
Number of subjects: 28
Study 30149982 — intervention group
Group type: COMPARATOR
Intervention: Problem-based learning (PBL)
Number of subjects: 28
Study 28392807 — intervention group
Group type: EXPERIMENTAL
Intervention: setipiprant 1000 mg b.i.d. (Phase 2 trial)
Number of subjects: 1209
Study 28392807 — intervention group
Group type: EXPERIMENTAL
Intervention: setipiprant 1000 mg b.i.d. (Phase 3 trial)
Number of subjects: 1209
Study 28392807 — intervention group
Group type: EXPERIMENTAL
Intervention: setipiprant 1000 mg b.i.d. (both trials)
Number of subjects: 1209
Study 28392807 — intervention group
Group type: COMPARATOR
Intervention: placebo (Phase 2 trial)
Number of subjects: 1209
Study 28392807 — intervention group
Group type: COMPARATOR
Intervention: cetirizine (active control in both trials)
Number of subjects: 1209
Study 26611245 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline
Number of subjects: 20
Study 26611245 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study 26611245 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O
Number of subjects: 20
Study 24650461 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical interventions (including gastroschisis closure and ductus arteriosus ligation)
Number of subjects: 724
Study 22468715 — intervention group
Group type: EXPERIMENTAL
Intervention: The Great Escape computer game intervention
Number of subjects: 0
Study 22468715 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified what intervention was used)
Number of subjects: 0
Study 21050201 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping and support group interventions
Number of subjects: 108
Study 21050201 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 108
Study 17458505 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD2171 at 2.5 mg
Number of subjects: 26
Study 17458505 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD2171 at 20 mg
Number of subjects: 26
Study 17458505 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD2171 at 30 mg
Number of subjects: 26
Study 17458505 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD2171 (various doses)
Number of subjects: 26
Study 17458505 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD2171
Number of subjects: 26
Study 15138906 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ropivacaine plus 0.1 mg morphine
Number of subjects: 60
Study 15138906 — intervention group
Group type: COMPARATOR
Intervention: 15 mg bupivacaine plus 0.1 mg morphine
Number of subjects: 60
Study 12011536 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam 4.5 g q6h
Number of subjects: 12
Study 12011536 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin/tazobactam 3.375 g q4h
Number of subjects: 12
Study 9657626 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 31
Study 9657626 — intervention group
Group type: COMPARATOR
Intervention: Sham smoking
Number of subjects: 31
Study 7657193 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam/HAES 6%
Number of subjects: 39
Study 7657193 — intervention group
Group type: COMPARATOR
Intervention: Naftidrofuryl/HAES 6%
Number of subjects: 39
Study 2683900 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipstick leukocyte esterase test (LET)
Number of subjects: 800
Study 2683900 — intervention group
Group type: COMPARATOR
Intervention: Routine cell count determinations and cultures
Number of subjects: 800
Study 773497 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical regimen (simple mastectomy and radiotherapy)
Number of subjects: 2268
Study 773497 — intervention group
Group type: COMPARATOR
Intervention: Conservative policy (simple mastectomy alone)
Number of subjects: 2268
Study 31362081 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33 °C
Number of subjects: 151
Study 31362081 — intervention group
Group type: COMPARATOR
Intervention: Targeted temperature management at 36 °C
Number of subjects: 151
Study 31362081 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher heart rate during TTM
Number of subjects: 151
Study 31362081 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower stroke volume during TTM
Number of subjects: 151
Study 31362081 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing lactate during TTM
Number of subjects: 151
Study 31362081 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower mean arterial pressure during TTM
Number of subjects: 151
Study 28129749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg
Number of subjects: 143
Study 28129749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 1.25 mg (switched to 0.5 mg)
Number of subjects: 143
Study 28129749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg (continuous treatment)
Number of subjects: 143
Study 28129749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod (both dosages)
Number of subjects: 143
Study 28129749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod
Number of subjects: 143
Study 28129749 — intervention group
Group type: COMPARATOR
Intervention: Placebo (initial group switched to fingolimod)
Number of subjects: 143
Study 26545513 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention
Number of subjects: 42
Study 26545513 — intervention group
Group type: COMPARATOR
Intervention: Traditional Treatment
Number of subjects: 42
Study 23870217 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgicel (oxidized cellulose patch)
Number of subjects: 190
Study 23870217 — intervention group
Group type: COMPARATOR
Intervention: Conventional procedures (ligatures and bipolar electrocautery)
Number of subjects: 190
Study 22232914 — intervention group
Group type: EXPERIMENTAL
Intervention: cycloferon liniment
Number of subjects: 80
Study 19934870 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard polyvinyl chloride tracheal tubes
Number of subjects: 347
Study 19934870 — intervention group
Group type: COMPARATOR
Intervention: Standard wire‐reinforced tracheal tubes
Number of subjects: 347
Study 19934870 — intervention group
Group type: COMPARATOR
Intervention: Silicone wire‐reinforced tubes
Number of subjects: 347
Study 16367899 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral acoustic stimulation (CAS) in myasthenic patients
Number of subjects: 16
Study 16367899 — intervention group
Group type: COMPARATOR
Intervention: Contralateral acoustic stimulation (CAS) in control group
Number of subjects: 16
Study 16367899 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral acoustic stimulation (CAS) in myasthenic patients utilizing masking effect
Number of subjects: 16
Study 16367899 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment after 2 months in myasthenic patients
Number of subjects: 16
Study 15192621 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose levothyroxine (12.0 microg/kg per day)
Number of subjects: 18
Study 15192621 — intervention group
Group type: COMPARATOR
Intervention: Control group (40 children)
Number of subjects: 18
Study 11251517 — intervention group
Group type: EXPERIMENTAL
Intervention: Anderson-Hynes pyeloplasty
Number of subjects: 41
Study 9333592 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 4,000 mg
Number of subjects: 43
Study 9333592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 9333592 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium glutamate 2 x 1,000 mg intravenously
Number of subjects: 43
Study 9333592 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium (2 x 9 mmol)
Number of subjects: 43
Study 9333592 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium injection
Number of subjects: 43
Study 8507963 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative surgical technique (Group A)
Number of subjects: 40
Study 8507963 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgical technique (Group B)
Number of subjects: 40
Study 3304370 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD pacing
Number of subjects: 15
Study 3304370 — intervention group
Group type: COMPARATOR
Intervention: VVI pacing
Number of subjects: 15
Study 29386302 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS-guided fluid management
Number of subjects: 137
Study 29386302 — intervention group
Group type: COMPARATOR
Intervention: Control group (clinical information alone)
Number of subjects: 137
Study 27898068 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week yoga intervention
Number of subjects: 28
Study 27898068 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 28
Study 24722235 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic VSL#3 strains (D‐VSL#3, n=10)
Number of subjects: 20
Study 24722235 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with prednisone and metronidazole (D‐CT, n=10)
Number of subjects: 20
Study 24722235 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy dogs and archived intestinal tissues)
Number of subjects: 20
Study 23560384 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Thoughts and Actions (PTA)
Number of subjects: 120
Study 23560384 — intervention group
Group type: COMPARATOR
Intervention: Individual Support Program (ISP)
Number of subjects: 120
Study 20004480 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood stabilizers
Number of subjects: 144
Study 20004480 — intervention group
Group type: COMPARATOR
Intervention: Healthy unrelated controls
Number of subjects: 144
Study 20004480 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotypes in manic patients
Number of subjects: 144
Study 18991138 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU) intervention
Number of subjects: 1
Study 16682585 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone before PRP
Number of subjects: 9
Study 16682585 — intervention group
Group type: COMPARATOR
Intervention: PRP alone (control)
Number of subjects: 9
Study 15474871 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet-plus-exercise (DEX)
Number of subjects: 90
Study 15474871 — intervention group
Group type: COMPARATOR
Intervention: Exercise-only (EX)
Number of subjects: 90
Study 11770694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 120
Study 11770694 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine 10 mg
Number of subjects: 120
Study 11770694 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 9189306 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (GLU) feeding
Number of subjects: 7
Study 9189306 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose (FRU) feeding
Number of subjects: 7
Study 9189306 — intervention group
Group type: COMPARATOR
Intervention: Sweetened placebo (PLA)
Number of subjects: 7
Study 7920886 — intervention group
Group type: EXPERIMENTAL
Intervention: High resolution ultrasonography (US)
Number of subjects: 177
Study 7920886 — intervention group
Group type: COMPARATOR
Intervention: Tc‐99m scintigraphy
Number of subjects: 177
Study 3538446 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam premedication
Number of subjects: 150
Study 3538446 — intervention group
Group type: COMPARATOR
Intervention: Oral trimeprazine, droperidol and methadone (TDM)
Number of subjects: 150
Study 3538446 — intervention group
Group type: COMPARATOR
Intervention: No sedative medication (unsedated group)
Number of subjects: 150
Study 3538446 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 150
Study 3538446 — intervention group
Group type: COMPARATOR
Intervention: TDM
Number of subjects: 150
Study 31270962 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sleep duration
Number of subjects: 202
Study 31270962 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap duration
Number of subjects: 202
Study 31270962 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep variability
Number of subjects: 202
Study 31270962 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep timing
Number of subjects: 202
Study 29975268 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 week immobilization
Number of subjects: 133
Study 29975268 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 weeks immobilization
Number of subjects: 133
Study 29975268 — intervention group
Group type: COMPARATOR
Intervention: 6 weeks immobilization
Number of subjects: 133
Study 26852375 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention program (PIP) with 12 weekly group sessions
Number of subjects: 223
Study 26852375 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 223
Study 24892447 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Aid (DA)
Number of subjects: 146
Study 24892447 — intervention group
Group type: COMPARATOR
Intervention: Standard trial consent materials (control group)
Number of subjects: 146
Study 22409104 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in a functional dyad (team)
Number of subjects: 0
Study 22409104 — intervention group
Group type: COMPARATOR
Intervention: Working alone
Number of subjects: 0
Study 19817814 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous electrical stimulation of the hippocampus bilaterally (on)
Number of subjects: 2
Study 19817814 — intervention group
Group type: COMPARATOR
Intervention: No stimulation (off)
Number of subjects: 2
Study 19817814 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous electrical stimulation of the hippocampus bilaterally
Number of subjects: 2
Study 18047891 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-minute stage exercise testing protocol
Number of subjects: 42
Study 18047891 — intervention group
Group type: COMPARATOR
Intervention: 3-minute stage exercise testing protocol
Number of subjects: 42
Study 15228199 — intervention group
Group type: EXPERIMENTAL
Intervention: Cementum annulation technique applied to older individuals (n=34)
Number of subjects: 58
Study 15228199 — intervention group
Group type: COMPARATOR
Intervention: Cementum annulation technique applied to younger individuals (n=24)
Number of subjects: 58
Study 15228199 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of age determination between men and women
Number of subjects: 58
Study 15228199 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of modern teeth and teeth from the 19th century
Number of subjects: 58
Study 12399222 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhosis group (n=6)
Number of subjects: 15
Study 12399222 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis group (n=3)
Number of subjects: 15